The present EMT line would thus offer an excellent model that will lead to the detailed analysis of the underlying mechanism and thereby development of new effective therapy for EGFR targeting drug-resistant HNSCC with EMT phenotype. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.